The Princess of Wales announced she's in remission from cancer in January 2025 — nearly a year after sharing her diagnosis ...

Months after Kate Middleton first revealed her cancer diagnosis in March 2024, she confirmed she'd finished chemotherapy in ...

Taguig City, Philippines - We Hope Medical Group, a premier healthcare provider, has expanded its services with the opening ...

Preview ASCO 2026 late-breaking cancer trials—from TNBC ADC survival gains to lung, liver, prostate and myeloma readouts ...

"He's missed a year of school and he just wants to be like everybody else," said Penny Saltmarsh of her son, Arthur ...

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...

Reported up to a 37% reduction of parenteral support in MVID patients and about 12% reduction in short bowel syndrome ...

FDA approval brings Enhertu into early breast cancer treatment, boosting response before surgery and cutting recurrence risk ...

Chemotherapy drugs like doxorubicin and etoposide work by snapping a cancer cell’s DNA in two. The breaks are supposed to be ...

Kate Middleton’s health journey reshaped royal life over the past two years. Now, the Princess of Wales is back at work with ...

Zaya Swart, a spirited little girl with a big personality, brings joy to those around her, even as she battles the rare ...

Sacituzumab tirumotecan (sac-TMT)(佳泰莱®) plus pembrolizumab versus pembrolizumab as first-line treatment for PD-L1 positive advanced NSCLC: Results from the randomized, controlled, registrational Phase ...